当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析 - 现金流量表

我武生物

(300357)

  

流通市值:105.29亿  总市值:113.57亿
流通股本:4.85亿   总股本:5.24亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金878,914,365.09532,170,795.94228,767,671.71,101,022,588.47
  收到的税费返还10,792,578.910,221,578.83--
  收到其他与经营活动有关的现金26,443,611.2711,469,466.461,640,423.6233,074,833.86
  经营活动现金流入小计916,150,555.26553,861,841.23230,408,095.321,134,097,422.33
  购买商品、接受劳务支付的现金13,538,296.957,101,745.573,092,636.1828,296,506.98
  支付给职工以及为职工支付的现金221,267,345.96146,981,054.9878,362,454.12293,250,722.49
  支付的各项税费141,830,637.882,707,917.2530,501,111.67123,177,647.63
  支付其他与经营活动有关的现金194,684,420.76127,563,275.0963,402,753.79266,176,798.62
  经营活动现金流出小计571,320,701.47364,353,992.89175,358,955.76710,901,675.72
  经营活动产生的现金流量净额344,829,853.79189,507,848.3455,049,139.56423,195,746.61
二、投资活动产生的现金流量:
  收回投资收到的现金1,192,930,615.38631,542,465.38303,197,865.381,101,588,389
  取得投资收益收到的现金8,069,191.63,087,706.861,291,608.793,496,824.76
  处置固定资产、无形资产和其他长期资产收回的现金净额17,333.716,283.71211.71-
  收到的其他与投资活动有关的现金1,588,000100,000100,000-
  投资活动现金流入小计1,202,605,140.69634,736,455.95304,589,685.881,105,085,213.76
  购建固定资产、无形资产和其他长期资产支付的现金33,081,699.4727,342,279.219,366,907.59119,347,815.69
  投资支付的现金1,072,246,479.2546,816,821.66238,672,0001,224,670,000
  支付其他与投资活动有关的现金2,451,118.252,451,118.252,451,118.2532,946,107.45
  投资活动现金流出小计1,107,779,296.92576,610,219.11260,490,025.841,376,963,923.14
  投资活动产生的现金流量净额94,825,843.7758,126,236.8444,099,660.04-271,878,709.38
三、筹资活动产生的现金流量:
  取得借款收到的现金5,000,0005,000,0005,000,00020,000,000
  筹资活动现金流入小计5,000,0005,000,0005,000,00020,000,000
  偿还债务支付的现金10,000,0005,000,0005,000,00027,628,987.85
  分配股利、利润或偿付利息支付的现金130,977,201.3952,424,268.0652,393,601.39115,298,368.9
  支付其他与筹资活动有关的现金4,048,788.992,553,951.181,538,824.076,181,817.09
  筹资活动现金流出小计145,025,990.3859,978,219.2458,932,425.46149,109,173.84
  筹资活动产生的现金流量净额-140,025,990.38-54,978,219.24-53,932,425.46-129,109,173.84
四、汇率变动对现金及现金等价物的影响-14,376.27-11,105.96-6,424.71-7,171.42
五、现金及现金等价物净增加额299,615,330.91192,644,759.9845,209,949.4322,200,691.97
  加:期初现金及现金等价物余额120,062,978.78120,062,978.78120,062,978.7897,862,286.81
  期末现金及现金等价物余额419,678,309.69312,707,738.76165,272,928.21120,062,978.78
补充资料:
  净利润-208,576,920.39-368,089,245.89
  资产减值准备-3,372,352.37-5,611,447.2
  固定资产和投资性房地产折旧-20,460,224.53-35,408,140.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-20,460,224.53-35,408,140.69
  无形资产摊销-7,091,801.96-14,573,789.77
  长期待摊费用摊销-1,429,618.26-1,704,146.99
  处置固定资产、无形资产和其他长期资产的损失----630,073.33
  固定资产报废损失-93,890.63-344,118.81
  公允价值变动损失--3,312,651.67--3,425,972.25
  财务费用-406,213.73-793,087.05
  投资损失--29,032,597.07--2,721,381.62
  递延所得税--475,793.42--114,111.15
  其中:递延所得税资产减少--475,862.02-24,690.82
    递延所得税负债增加-68.6--138,801.97
  存货的减少-1,977,053.61-2,975,746.21
  经营性应收项目的减少--36,781,531.24-9,025,610.68
  经营性应付项目的增加-13,635,903.69--14,206,156.54
  现金的期末余额-312,707,738.76-120,062,978.78
  减:现金的期初余额-120,062,978.78-97,862,286.81
  现金及现金等价物的净增加额-192,644,759.98-22,200,691.97
公告日期2026-10-242026-08-282026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑